Technology - Sponsored Research
It is the policy of the Company to seek outstanding scientific leaders and independent investigators as collaborators in mutually beneficial projects. The following projects are sponsored in part by the company:
>Dr. Franco DeMayo at Baylor College of Medicine in Houston, Texas is studying, "Ablation of Secretory Gene Expression in Transgenic Mice". Dr. DeMayo was one of the first investigators to develop transgenic mice and is an integral member of the Center for Cell and Gene Therapy group at Baylor College of Medicine.
- Dr. Cy A. Stein at Columbia University in New York City, is a well-published investigator in the world of Antisense Therapies, in particular prostate cancer, and is the co-editor of Antisense & Nucleic Acid Drug Development Journal. Dr. Stein is conducting a study entitled, "Antisense Therapies in Human Prostate and Bladder Cancer."
- Dr. Peter Glazer at Yale University was the first investigator to provide research data on the use of our ssDNA expression technology in Triplex applications. This study, "Test of the ssDNA Vector System for Generation of Triplex-Forming Oligonucleotides in Mice", conducted by Dr. Glazer has shown positive results for the triplex application of the ssDNA expression system for gene conversion as previously demonstrated in Dr. Glazer's laboratory.
- Dr. Jeffery Actor, Associate Professor at the University of Texas Health Science Center Houston, Texas is conducting a study entitled, "In vivo proof of concept experiment for anti-bacterial DNA preparation".
- Dr. Charles Densmore, Assistant Professor at Baylor College of Medicine, Houston, Texas is conducting a study entitled, "PEI aerosol delivery of ssDNA expression vector".
- Drs. Lyuba Benimetskaya and Cy Stein at Albert Einstein College of Medicine, New York are conducting a study entitled, "Down Regulate Gene Expression in Melanoma Cells using Antisense ODNs Generated by CYGX ssDNA Expression Vectors".
